TME analysis showed that combined treatment significantly increased the number of tumor-infiltrating Th9 cells, enhanced the antitumor effect of CD8+ T cells, and remodeled the tumor immunosuppressive microenvironment and the tumor elimination efficacy in the mice models. The gene discussed is CD8A; the disease is neoplasm.